INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 103 filers reported holding INSMED INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,813,603 | +3239.7% | 269,846 | +2690.8% | 0.05% | +4900.0% |
Q2 2023 | $204,016 | -74.5% | 9,669 | -75.8% | 0.00% | -80.0% |
Q4 2022 | $799,899 | -90.4% | 40,035 | -89.6% | 0.01% | -89.4% |
Q3 2022 | $8,321,000 | +741.4% | 386,305 | +669.9% | 0.05% | +683.3% |
Q2 2022 | $989,000 | +382.4% | 50,173 | +474.9% | 0.01% | +200.0% |
Q1 2022 | $205,000 | -92.0% | 8,727 | -90.8% | 0.00% | -92.0% |
Q4 2021 | $2,577,000 | +392.7% | 94,618 | +398.3% | 0.02% | +257.1% |
Q3 2021 | $523,000 | +2173.9% | 18,988 | +2224.1% | 0.01% | – |
Q2 2021 | $23,000 | -93.9% | 817 | -92.6% | 0.00% | -100.0% |
Q1 2021 | $374,000 | -40.3% | 10,978 | -41.6% | 0.01% | -44.4% |
Q4 2020 | $626,000 | -67.5% | 18,803 | -68.7% | 0.01% | -69.0% |
Q3 2020 | $1,928,000 | +959.3% | 59,996 | +809.0% | 0.03% | +866.7% |
Q2 2020 | $182,000 | -80.6% | 6,600 | -88.7% | 0.00% | -88.0% |
Q1 2020 | $939,000 | +663.4% | 58,596 | +1038.2% | 0.02% | +1150.0% |
Q4 2019 | $123,000 | -63.8% | 5,148 | -73.3% | 0.00% | -71.4% |
Q3 2019 | $340,000 | +4.6% | 19,300 | +51.8% | 0.01% | +16.7% |
Q2 2019 | $325,000 | +65.8% | 12,712 | +88.7% | 0.01% | 0.0% |
Q1 2019 | $196,000 | -74.5% | 6,737 | -88.5% | 0.01% | -83.3% |
Q4 2018 | $769,000 | +392.9% | 58,598 | +660.4% | 0.04% | +300.0% |
Q3 2018 | $156,000 | -22.0% | 7,706 | -9.0% | 0.01% | -10.0% |
Q2 2018 | $200,000 | +233.3% | 8,468 | +340.1% | 0.01% | +233.3% |
Q3 2017 | $60,000 | +328.6% | 1,924 | +140.5% | 0.00% | +200.0% |
Q1 2017 | $14,000 | -90.7% | 800 | -92.3% | 0.00% | -90.0% |
Q3 2016 | $151,000 | -45.7% | 10,387 | -63.2% | 0.01% | -37.5% |
Q2 2016 | $278,000 | +47.9% | 28,238 | +172.4% | 0.02% | +45.5% |
Q4 2015 | $188,000 | -34.9% | 10,365 | -33.5% | 0.01% | -26.7% |
Q3 2015 | $289,000 | +28800.0% | 15,584 | +20139.0% | 0.02% | – |
Q4 2014 | $1,000 | 0.0% | 77 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | -99.5% | 77 | -99.3% | 0.00% | -100.0% |
Q2 2014 | $214,000 | – | 10,724 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |